Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Key mutations in the spike protein of SARS‐CoV‐2 affecting neutralization resistance and viral internalization
Qiong Wang, Sheng‐Bao Ye, Zhijian Zhou, et al.
Journal of Medical Virology (2022) Vol. 95, Iss. 1
Open Access | Times Cited: 29

Showing 1-25 of 29 citing articles:

Inferring effects of mutations on SARS-CoV-2 transmission from genomic surveillance data
Brian Lee, Ahmed Abdul Quadeer, Muhammad S. Sohail, et al.
Nature Communications (2025) Vol. 16, Iss. 1
Open Access | Times Cited: 2
The Era of the FLips: How Spike Mutations L455F and F456L (and A475V) Are Shaping SARS-CoV-2 Evolution
Daniele Focosi, Pietro Giorgio Spezia, Federico Gueli, et al.
Viruses (2023) Vol. 16, Iss. 1, pp. 3-3
Open Access | Times Cited: 19
Chronic shedding of a SARS-CoV-2 Alpha variant in wastewater
Michael J. Conway, Hannah Yang, Lauren A. Revord, et al.
BMC Genomics (2024) Vol. 25, Iss. 1
Open Access | Times Cited: 6
Spatiotemporal dynamics and epidemiological impact of SARS-CoV-2 XBB lineage dissemination in Brazil in 2023
Ighor Arantes, Marcelo Ferreira da Costa Gomes, Kimihito Ito, et al.
Microbiology Spectrum (2024) Vol. 12, Iss. 3
Open Access | Times Cited: 6
SARS‐CoV‐2 intrahost evolution in immunocompromised patients in comparison with immunocompetent populations after treatment
Akram Sadat Ahmadi, Sevrin Zadheidar, Kaveh Sadeghi, et al.
Journal of Medical Virology (2023) Vol. 95, Iss. 6
Closed Access | Times Cited: 11
Adaptive evolution of SARS-CoV-2 during a persistent infection for 521 days in an immunocompromised patient
Hanno Schmidt, Luca Aroha Schick, Jürgen Podlech, et al.
npj Genomic Medicine (2025) Vol. 10, Iss. 1
Open Access
Characterization of SARS-CoV-2 intrahost genetic evolution in vaccinated and non-vaccinated patients from the Kenyan population
Doreen Lugano, Kennedy W. Mwangi, Bernard Mware, et al.
medRxiv (Cold Spring Harbor Laboratory) (2025)
Open Access
Characterization of SARS-CoV-2 intrahost genetic evolution in vaccinated and non-vaccinated patients from the Kenyan population
Doreen Lugano, Kennedy W. Mwangi, Bernard Mware, et al.
Journal of Virology (2025)
Open Access
Neutralization sensitivity of SARS-CoV-2 Omicron variants FL.1 and GE.1 by therapeutic antibodies and XBB sera
Joseph Lee, Youichi Naoe, Uikyu Bang, et al.
Virology (2024) Vol. 595, pp. 110067-110067
Open Access | Times Cited: 2
Humoral and Cellular Immune Response to SARS-CoV-2 S and N Proteins
Z. E. Afridonova, А. П. Топтыгина, Ilya S. Mikhaylov
Biochemistry (Moscow) (2024) Vol. 89, Iss. 5, pp. 872-882
Closed Access | Times Cited: 2
Identification of antibody-resistant SARS-CoV-2 mutants via N4-Hydroxycytidine mutagenesis
Priya Kumar, Xiaoxiao Zhang, Rahul Shaha, et al.
Antiviral Research (2024) Vol. 231, pp. 106006-106006
Open Access | Times Cited: 2
Risk assessment of SARS-CoV-2 replicating and evolving in animals
Jin Zhao, Mei Kang, Hongyan Wu, et al.
Trends in Microbiology (2023) Vol. 32, Iss. 1, pp. 79-92
Open Access | Times Cited: 5
Sequence signatures within the genome of SARS-CoV-2 can be used to predict host source
Josip Rudar, Peter Kruczkiewicz, Oksana Vernygora, et al.
Microbiology Spectrum (2024) Vol. 12, Iss. 4
Open Access | Times Cited: 1
Duration of antibody response to the receptor binding domain of SARS-CoV-2 in infected or vaccinated individuals – A one year retrospective cohort study
Martin Pasev, Angelina Trifonova, Andrey Velichkov, et al.
International Immunopharmacology (2024) Vol. 133, pp. 112084-112084
Open Access | Times Cited: 1
Ongoing evolution of SARS-CoV-2 drives escape from mRNA vaccine-induced humoral immunity
Alex Roederer, Yi Cao, Kerri St. Denis, et al.
Cell Reports Medicine (2024) Vol. 5, Iss. 12, pp. 101850-101850
Open Access | Times Cited: 1
The impact of S2 mutations on Omicron SARS-CoV-2 cell surface expression and fusogenicity
Alba Escalera, Manon Laporte, S. Richard Turner, et al.
Emerging Microbes & Infections (2023) Vol. 13, Iss. 1
Open Access | Times Cited: 3
Understanding the Relationship of the Human Bacteriome with COVID-19 Severity and Recovery
Hassan Zafar, Milton H. Saier
Cells (2023) Vol. 12, Iss. 9, pp. 1213-1213
Open Access | Times Cited: 2
Assessing the interaction between hemoglobin and the receptor binding domain of SARS-CoV-2 spike protein through MARTINI coarse-grained molecular dynamics
Jessica Gasparello, Marco Verona, Adriana Chilin, et al.
International Journal of Biological Macromolecules (2023) Vol. 253, pp. 127088-127088
Open Access | Times Cited: 2
Molecular Ion Channel Blockers of Influenza A and SARS-CoV-2 Viruses
Yu. N. Vorobjev
Molecular Biology (2024) Vol. 58, Iss. 4, pp. 773-789
Closed Access
SARS-CoV-2 and Environmental Changes: The Perfect Storm
Mario Caldarelli, Pierluigi Rio, Vincenzo Giambra, et al.
Current Issues in Molecular Biology (2024) Vol. 46, Iss. 11, pp. 11835-11852
Open Access
Features of the humoral and cellular immune response to S- and N-proteins of the SARS-CoV-2 virus
Z. E. Afridonova, А. П. Топтыгина, Ilya S. Mikhaylov
Биохимия (2024) Vol. 89, Iss. 5, pp. 854-865
Closed Access
Molecular Ion Channel Blockers of Influenza A and SARS-CoV-2 Viruses
Yu. N. Vorobjev
Молекулярная биология (2024) Vol. 58, Iss. 4
Closed Access
Mutation Analysis of SARS-CoV-2 Variants Isolated from Symptomatic Cases from Andhra Pradesh, India
Nagaraja Mudhigeti, Kodavala Sireesha, Anagoni Srikar, et al.
Viruses (2023) Vol. 15, Iss. 8, pp. 1656-1656
Open Access | Times Cited: 1
Characterization of SARS-CoV-2 genetic evolution in vaccinated and non-vaccinated patients from the Kenyan population
Samuel O. Oyola
Research Square (Research Square) (2023)
Open Access | Times Cited: 1
Page 1 - Next Page

Scroll to top